Publication | Open Access
Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer
47
Citations
12
References
2023
Year
In patients with locally advanced or metastatic K-Ras wild-type PC, nimotuzumab plus gemcitabine significantly improved OS and PFS with a good safety profile.
| Year | Citations | |
|---|---|---|
Page 1
Page 1